F.D.A. Panel Rejects MDMA-Aided Therapy for PTSDThe FDA advisory panel rejected MDMA-assisted therapy for PTSD due to concerns about study designs, participants' ability to guess MDMA use, and potential biases.
MDMA's Future As A Treatment For PTSD Is In QuestionThe FDA expert panel rejected MDMA as a treatment for PTSD due to effectiveness and risk concerns, despite existing use in Australia.